The intricate interplay among IGF-1R, IGF-1, and GM-CSF highlights potential therapeutic targets for precise control of NPC bone metastasis, providing valuable insights for developing targeted interventions. This evidence concerns the gene IGF1 and nasopharyngeal carcinoma.